HCN4 channels are expressed in the human sinoatrial node (SAN) and conduct the hyperpolarization-activated 'funny current', I f , also known as 'pacemaker current'. Several loss-of-function mutations in the HCN4 gene have been associated with human sinus bradycardia. Clinical observations suggest that bradycardic effects are present at all levels of autonomic tone.
Introduction
The hyperpolarization-activated 'funny current' (I f ), also known as 'pacemaker current', is a key player in sinoatrial node (SAN) pacemaker activity. This (mainly) inward current of mixed ionic nature is a determinant of the spontaneous depolarization that underlies SAN pacemaker activity and thus a modulator of pacing rate [1, 2] . The membrane ionic I f channel is constituted by four hyperpolarization-activated, cyclic-nucleotide-gated (HCN) subunits. The HCN4 protein, which is encoded by the HCN4 gene, is the dominant HCN isoform in rabbit and human SAN [3] [4] [5] [6] .
Since 2003, several loss-of-function mutations in the HCN4 gene have been associated with human sinus bradycardia [7, 8] . For example, Nof et al. [9] reported on an Israeli family with the G480R mutation. Average resting heart rate (mean ± SEM) was 49 ± 12 bpm (range 36-72 bpm) in the 7 mutation carriers vs. 73 ± 11 bpm (range 55-89 bpm) in the 8 non-affected family members. Similarly, Laish-Farkash et al. [10] reported on three families of Moroccan Jewish decent with the A485V mutation. The average heart rate of 14 mutation carriers was 58 ± 6 bpm (range 49-70 bpm), whereas that of 5 non-carriers was 77 ± 12 bpm (range 59-91 bpm). In a single German family with the 695X mutation, Schweizer et al. [11] observed an average heart rate of 56 ± 5 bpm (range 47-61 bpm) in 7 mutation carriers vs. 72 ± 10 bpm (range 58-86 bpm) in 6 non-carriers. The clinical data of Nof et al. [9] , Laish-Farkash et al. [10] , and Schweizer et al. [11] are not limited to the average heart rate. They also reported the minimum and maximum heart rate obtained with 24-hour Holter recording. These data are summarized in Table 1 and visualized in Figure 1 .
The G480R, A485V, and 695X mutations in HCN4 all reduce the minimum, average, and maximum heart rate by 20-30%, likely due to mutation-induced changes in the expression and kinetics of the HCN4-encoded I f channels. Voltage clamp experiments on wild-type and heterozygous mutant HCN4 channels expressed in cell lines revealed changes in the expression and kinetics of these channels [12, 13] , but the functional effects of these changes on human SAN pacemaker activity remain unresolved.
In the present study, we attempted to assess the effects of the aforementioned HCN4 mutations on human SAN pacemaker activity by incorporating the experimentally identified changes in expression and kinetics of HCN4 [14] . This model allows different levels of autonomic tone through the simulated administration of acetylcholine (ACh; vagal tone) or isoprenaline (Iso; -adrenergic tone).
Methods
Mutations in HCN4 were implemented in the CellML code [15] of the Fabbri et al. model [14] by scaling the fully-activated conductance of I f and/or shifting its voltage dependence, based on the data from literature obtained in voltage-clamp experiments on HCN4 channels expressed in cell lines [12, 13] . The G480R mutation was simulated through a 50% reduction in fullyactivated conductance (i.e., a scaling factor of 0.5) and a 15 mV shift in voltage dependence, whereas a scaling factor of 0.33 and a 30 mV shift were used to simulate the A485V mutation. The loss of cAMP sensitivity in case of the 695X mutation was simulated by a fixed 10.1 mV shift in voltage dependence, in line with the maximum effect of acetylcholine. The default Fabbri et al. model [14] has a beating rate of 74 bpm. This rate was lowered to 49 bpm (vagal tone) through the simulated administration of 20 nM ACh. The major effects of the administration of ACh are the activation of the ACh-activated potassium current I K,ACh , which is zero in the default model, and the inhibition of I f through a negative shift in its voltage dependence [14] . A beating rate of 140 bpm ( -adrenergic tone) was obtained through the simulated administration of Iso, tuning the parameters affected by Iso to arrive at this beating rate. The simulated effects of Iso included a +10 mV shift in the voltage dependence of I f .
The CellML code was edited and run in the Cellular Open Resource (COR) environment [16] , version 0.9.31.1409. All simulations were run for a sufficiently long time to reach steady-state behaviour. Fig. 2A . The amplitude of I f is 1 pA, whereas the amplitude of the net inward current is 2 pA (not shown). Thus, I f is an important inward current during the diastolic depolarization phase. The inhibition of I f by ACh contributes to the increase in cycle length to 1,231 ms ( Fig. 2A, blue traces) . The application of Iso stimulates I f and decreases cycle length to 429 ms ( Fig. 2A, red traces) . A loss-of-function mutation in HCN4 will lead to a smaller I f , and thus a decrease in inward current during diastolic depolarization, at all levels of autonomic tone.
Results

Autonomic modulation
3.2.
Mutations in HCN4 Fig. 2 , B-D, shows the effects of mutations in HCN4 on the pacemaker activity of the model cell at different levels of autonomic tone. The G480R mutation (Fig. 2B ) reduces I f by 50%. As a result, the cycle length increases from 813 to 961 ms (+18%) under control conditions. With ACh and Iso, the cycle length increases from 1,231 to 1,503 ms (+22%) and from 429 to 519 ms (+21%), respectively.
With a 30 mV shift in voltage dependence and a scaling factor of 0.33, the A485V mutation is more 'severe' than the G480R mutation, which shows a 15 mV shift and a scaling factor of 0.5. This is reflected in a smaller amplitude of I f and slower pacemaking (Fig. 2C) .
The cycle length now amounts to 1,018 ms under control conditions (+25%) and to 1,618 ms (+31%) and 599 ms (+40%) with ACh and Iso, respectively.
The functional effects are somewhat different for the 695X mutation, which leads to a loss of cAMP sensitivity of I f rather than a shift in its voltage dependence and/or a reduction in its fully-activated conductance. With an increase in cycle length to 1,326 ms (+8%), the effects of the 695X mutation are relatively mild at vagal tone (Fig.  2D ). Under control conditions and with Iso, cycle length increases to 924 ms (+14%) and to 550 ms (+28%), respectively.
The functional effects of the three different mutations are summarized in Fig. 3 , which shows the beating rate of the model cell at different levels of autonomic tone for each of the mutations. The grey bars show the beating rate in the absence of a mutation.
Discussion
We assessed the effects of three different HCN4 mutations (G480R, A485V, and 695X) on human SAN pacemaker activity at different levels of autonomic tone, using the model of a single human SAN pacemaker cell that was recently developed by Fabbri et al. [14] . These particular mutations were selected for their different electrophysiological effects and availability of clinical data on minimum, average, and maximum heart rates in multiple mutation carriers as well as non-carriers from the same family. The effects of the mutations on the beating rate of the model cell match the clinically observed effects on heart rate, at least qualitatively.
There are several factors, both physiological and nonphysiological, that obscure a direct quantitative comparison between our simulation results and the available clinical data. One is the hyperpolarizing effect of the surrounding atrium in the intact heart, which will result in a more prominent role of I f in vivo. Another is that experimental data from voltage clamp experiments on mutant HCN4 channels are often incomplete and potentially strongly dependent on the expression system and experimental protocol that were employed.
Conclusion
We conclude that experimentally observed changes in the expression and kinetics of I f channels can explain the clinically observed bradycardic effects of loss-of-function mutations in HCN4 at different levels of autonomic tone.
